SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-13-127467
Filing Date
2013-03-27
Accepted
2013-03-26 21:57:55
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d444183d10ka.htm 10-K/A 50888
2 EX-31.1 d444183dex311.htm EX-31.1 9490
3 EX-31.2 d444183dex312.htm EX-31.2 9562
4 EX-32.1 d444183dex321.htm EX-32.1 5230
  Complete submission text file 0001193125-13-127467.txt   3915318

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20121231.xml EX-101.INS 471927
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20121231.xsd EX-101.SCH 49945
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20121231_cal.xml EX-101.CAL 44524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20121231_def.xml EX-101.DEF 211761
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20121231_lab.xml EX-101.LAB 365550
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20121231_pre.xml EX-101.PRE 290014
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52228 | Film No.: 13718146
SIC: 8731 Services-Commercial Physical & Biological Research